BioInsights - Cell Therapy Materials & Upstream Processing/Analytics - spotlight

CELL & GENE THERAPY INSIGHTS

Cell Therapy Materials & Upstream Processing/Analytics

March 2023
Cell Therapy Materials & Upstream Processing/Analytics

Commentary

Overcoming challenges to CAR-T cell therapies in India

Overcoming challenges to CAR-T cell therapies in India

A Uppal, R Chakrabarti, N Chirmule et al.
8 March 2023
Read

Interview

Ensuring success in working with apheresis centers

Ensuring success in working with apheresis centers

Suzanne Kamps
2 March 2023
Read
Bridging the knowledge gap in donor cellular starting material quality & variability

Bridging the knowledge gap in donor cellular starting material quality & variability

Yiran Zhou
22 February 2023
Read

Viewpoint

Distributed manufacturing models for ATMPs: can they work: do we understand the pitfalls?

Distributed manufacturing models for ATMPs: can they work: do we understand the pitfalls?

Mark Lowdell
2 March 2023
Read

Webinars

Understanding donor characteristics to improve allogeneic cell therapy outcomes for all

Understanding donor characteristics to improve allogeneic cell therapy outcomes for all

A Madbouly, M Maiers, S Sullivan
28 February 2023
Watch
Pain points to potential: Positioning process and analytical development for next-gen cell therapies

Pain points to potential: Positioning process and analytical development for next-gen cell therapies

Sarah Campion, Alex Sargent
9 March 2023
Watch
Improve your speed to therapy and drive efficiency by integrating supply chain and manufacturing

Improve your speed to therapy and drive efficiency by integrating supply chain and manufacturing

Robert Lutskus, Matthew Lakelin
21 March 2023
in 1
Days
Register
Scale-up and deliver allogeneic cell therapies to large patient populations

Scale-up and deliver allogeneic cell therapies to large patient populations

M Langtry, K Panchalingam, I Ben Nun
29 March 2023
in 9
Days
Register
Overcoming challenges to succeed when transitioning into a cGMP environment

Overcoming challenges to succeed when transitioning into a cGMP environment

Kris Wronski
30 March 2023
in 10
Days
Register
Cell therapy manufacturing and 21 CFR Part 11 compliance: Overview and considerations for instrument software

Cell therapy manufacturing and 21 CFR Part 11 compliance: Overview and considerations for instrument software

Ashley Smith, Brianna Volk
6 April 2023
in 17
Days
Register
Navigating bottlenecks in cell therapy manufacturing: A versatile and scalable platform solution

Navigating bottlenecks in cell therapy manufacturing: A versatile and scalable platform solution

Peter Yates
13 April 2023
in 24
Days
Register
Large-scale genome editing of primary human natural killer (NK) cells: A quest toward manufacture of clinically relevant CAR NK cells

Large-scale genome editing of primary human natural killer (NK) cells: A quest toward manufacture of clinically relevant CAR NK cells

Deepak Kumar
20 April 2023
in 31
Days
Register